Ian Gilham

Président chez GENEDRIVE PLC Fortune : 94 350 $ au 30/04/2026

Profil

Ian David Gilham is Non-Executive Chairman at Genedrive Plc since 2016, Chairman at Lifearc since 2023, Non-Executive Chairman at Cytox Ltd., Non-Executive Chairman at Pelago Bioscience AB, Director at Stowheath Ltd. since 2011, Director at Revona Bio Ltd. since 2023, and Non-Executive Director at Novacyt SAS since 2024.
Former roles include Chief Executive Officer at Axis-Shield Ltd. in 2012, Chairman at Revvity Discovery Ltd. in 2013, Non-Executive Chairman at Multiplicom NV from 2013 to 2017, Non-Executive Chairman at Horizon Discovery Group Ltd. from 2014 to 2020, Executive Chairman at Aptamer Group Plc in 2023, Non-Executive Chairman at Biosurfit SA, Independent Non-Executive Director at Ligand UK Ltd. from 2015 to 2018, Director at Fortis Cardiff Ltd. from 2013 to 2016, Non-Executive Director at Delta Diagnostics (UK) Ltd. from 2017 to 2019, Vice President-Pharmacogenetics & Diagnostics at GSK Plc, and Principal at GE Healthcare Ltd. (United Kingdom), Abbott Laboratories Ltd., and Celltech Ltd. Education includes a doctorate from the University of Bath and an undergraduate degree from The University of Wales.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
GENEDRIVE PLC 0,47 %	24/09/2025	7 505 961 ( 0,47 % )	94 350 $	30/04/2026

Postes actifs de Ian Gilham

Sociétés	Poste	Début
GENEDRIVE PLC	Président	11/05/2015
NOVACYT	Directeur/Membre du Conseil	31/10/2024
Revona Bio Ltd.	Directeur/Membre du Conseil	20/02/2023
Lifearc	Président	-
Cytox Ltd.	Président	-
Stowheath Ltd.	Directeur/Membre du Conseil	13/12/2011
Pelago Bioscience AB	Président	-

Anciens postes connus de Ian Gilham

Sociétés	Poste	Fin
APTAMER GROUP PLC	Président	21/08/2023
HORIZON DISCOVERY GROUP PLC	Président	23/12/2020
░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░░░ ░░	░░░░░░░░░░	░░░░░░░░░░